Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
February 14, 2025 through March 13, 2025, all patients enrolling to A081801 must first register to A151216. Starting March 14, 2025, A151216 will close to new patient accrual, and patients will register directly to A081801.